| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |